SynthesisDiabetes, obesity & metabolism2026
Antibiotic Exposure in Early Life and Risk of Type 1 Diabetes: A Meta-Analysis.
Synthesis in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEarly-life antibiotic use may increase the risk of childhood type 1 diabetes (T1D), potentially through gut microbiota dysbiosis and associated effects on immune development. This meta-analysis evaluated associations between early-life antibiotic use and T1D.
methodsA systematic search of PubMed, MEDLINE, Scopus and Web of Science was conducted up to June 2025, which focused on studies reporting associations between antibiotic use in the pre- and postnatal periods and childhood T1D. Pooled effect sizes were assessed using random effects models separately for prenatal and postnatal antibiotic exposure, with subgroup analyses by antibiotic course, class and spectrum. Study quality was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS).
resultsThe analysis included 20 studies (11 cohort, 9 case-control), encompassing > 1.5 million participants for prenatal and over 4 million for postnatal antibiotic exposure. A pooled effect size of 1.05 (95% CI 0.98-1.11) for prenatal exposure was found. Further analysis by antibiotic spectrum yielded no significant associations, likely due to the small number of studies. For postnatal antibiotic exposure, a pooled effect size of 1.07 (95% CI 1.01-1.14) was found, with estimates increasing with increased number of antibiotic courses: ≥ 2 courses, 1.11, 95% CI 1.02-1.20; and ≥ 5 courses, 1.14, 95% CI 1.00-1.30. Associations were stronger for broad-spectrum (1.13, 95% CI 1.03-1.23) than for narrow-spectrum antibiotics (1.08, 95% CI 0.93-1.26) but no significant associations were observed by antibiotic class. The impact of mode of obstetric delivery remained inconclusive across studies. The quality of the evidence was high.
conclusionThis meta-analysis suggests that early-life antibiotic use is associated with an increased risk of T1D, particularly with repeated courses and broad-spectrum agents. However, confidence in these findings is constrained by variability in study design and exposure definitions, as well as the potential for confounding by indication. While the observed associations are modest, they highlight the importance of judicious antibiotic prescribing in early life. Further large, well-designed prospective cohort studies are needed to clarify causality and better disentangle the effects of antibiotics from those of underlying infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.